These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Listed as ongoing, but also has a completion date||2004-002109-58||A Phase 3 Randomized, Open-label Comparative Study of Standard Whole Brain Radiation Therapy with Supplemental Oxygen, with or without Concurrent RSR13 efaproxiral , in Women with Brain Metasta...||2007-06-19||bad-data|
|Listed as ongoing, but also has a completion date||2006-002811-29||A Multi-center Phase 2 Open-label Study of RS -10-Propargyl-10-Deazaaminopterin pralatrexate with Vitamin B12 and Folic Acid Supplementation in Patients with Relapsed or Refractory Peripheral T ce...||2010-04-21||bad-data|
|Listed as ongoing, but also has a completion date||2007-004671-19||A Phase 2, Single-Arm Study of Pralatrexate in Patients with Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder||2011-09-22||bad-data|
|Not reported||2007-004673-26||Protocol PDX-012: A Randomized, Phase 2b, Multi-center Study of Pralatrexate Versus Erlotinib in Patients with Stage IIIB/IV Non-small Cell Lung Cancer After Failure of at Least 1 Prior Platinum-based...||2011-05-25||due-trials|
|Listed as ongoing, but also has a completion date||2008-006425-14||Phase 1/2 Study of Pralatrexate in Female Patients with Previously-treated Advanced or Metastatic Breast Cancer||2012-04-23||bad-data|
|Not reported||2010-022230-81||A Multi-center, Randomized, Phase 3 Study of Sequential Pralatrexate Versus Observation in Patients with Previously Undiagnosed Peripheral T-cell Lymphoma Who Have Achieved an Objective Response Follo...||2015-05-07||due-trials|
|Completed, but no date Terminated||2011-001309-29||A Multi-center, Open-label, Extension Study to Allow Continued Treatment of Patients Who Have Participated in Allos-sponsored Pralatrexate Studies||bad-data|